Literature DB >> 9534983

Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria.

G Weiss1, P E Thuma, G Biemba, G Mabeza, E R Werner, V R Gordeuk.   

Abstract

Cerebrospinal fluid samples from 130 children who presented with cerebral malaria were investigated to elucidate the impact of biopterin production, NO formation, and local immune activation on the clinical course of this disease. Biopterin levels were significantly lower in patients who were in a deeper coma (P = .02). Cerebrospinal fluid concentrations of NO were significantly higher in children who died than in survivors (P = .037); however, this was not the case for macrophage activation markers, neopterin, and soluble tumor necrosis factor receptor p75 (sTNFR-75). Biopterin, neopterin, and sTNFR-75 but not NO concentrations were significantly related to each other. Low biopterin levels in deep coma are compatible with an impaired local Th1 response, but the low levels could also be due to the scavenging of radicals or to decreased neurotransmitter synthesis. Local production of NO, most likely by nonimmune mechanisms, may be detrimental in cerebral malaria; however, this appears not to be the case for local Th1-mediated immune pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534983     DOI: 10.1086/515229

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Nitric oxide and infectious diseases.

Authors:  D Burgner; K Rockett; D Kwiatkowski
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

Review 2.  Cerebral malaria.

Authors:  C R Newton; T T Hien; N White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

3.  Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Authors:  Bert K Lopansri; Nicholas M Anstey; Gregory J Stoddard; Esther D Mwaikambo; Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Maurine R Hobbs; Marc C Levesque; J Brice Weinberg; Donald L Granger
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Increased pulmonary pressures and myocardial wall stress in children with severe malaria.

Authors:  Jacqueline J Janka; Ousmane A Koita; Broulaye Traoré; Josépha M Traoré; Fawaz Mzayek; Vandana Sachdev; Xunde Wang; Kassoum Sanogo; Lansana Sangaré; Laurel Mendelsohn; Henry Masur; Gregory J Kato; Mark T Gladwin; Donald J Krogstad
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

5.  Tetrahydrobiopterin deficiency in human rabies.

Authors:  R E Willoughby; T Opladen; T Maier; W Rhead; S Schmiedel; J Hoyer; C Drosten; C E Rupprecht; K Hyland; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-10-25       Impact factor: 4.982

6.  Association between seminal plasma neopterin and oxidative stress in male infertility: A case-control study.

Authors:  Tayebeh Ghiasvand; Mohammad Taghi Goodarzi; Gholamreza Shafiee; Alireza Zamani; Jamshid Karimi; Marzieh Ghorbani; Iraj Amiri
Journal:  Int J Reprod Biomed       Date:  2018-02

7.  Cerebrospinal Fluid Pterins, Pterin-Dependent Neurotransmitters, and Mortality in Pediatric Cerebral Malaria.

Authors:  Matthew P Rubach; Jackson P Mukemba; Salvatore M Florence; Bert K Lopansri; Keith Hyland; Ryan A Simmons; Charles Langelier; Sara Nakielny; Joseph L DeRisi; Tsin W Yeo; Nicholas M Anstey; J Brice Weinberg; Esther D Mwaikambo; Donald L Granger
Journal:  J Infect Dis       Date:  2021-10-28       Impact factor: 5.226

8.  Impaired systemic tetrahydrobiopterin bioavailability and increased oxidized biopterins in pediatric falciparum malaria: association with disease severity.

Authors:  Matthew P Rubach; Jackson Mukemba; Salvatore Florence; Bert K Lopansri; Keith Hyland; Alicia D Volkheimer; Tsin W Yeo; Nicholas M Anstey; J Brice Weinberg; Esther D Mwaikambo; Donald L Granger
Journal:  PLoS Pathog       Date:  2015-03-12       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.